Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Total 13F shares
-
2,785,956
-
Share change
-
+13,301
-
Total reported value
-
$5,517,109
-
Put/Call ratio
-
0%
-
Price per share
-
$1.98
-
Number of holders
-
22
-
Value change
-
+$81,616
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q4 2022
As of 31 Dec 2022,
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,785,956 shares.
The largest 10 holders included
Abingworth LLP, Nantahala Capital Management, LLC, AIGH Capital Management LLC, J. Goldman & Co LP, Worth Venture Partners, LLC, Clayton Partners LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.